Change search criteria ↓

Search results

1 384 projects found matching your search criteria:

  1. 201. The role of free fatty acid receptors in pathophysiology of the functional gastrointestinal tract disorders: new therapi…

    Principal investigator: dr hab. Maciej Stanisław Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM BIS 5, Panel: NZ7

  2. 202. Development of dual immuno-oligo- biosensors for monitoring and controlling of the metastatic colorectal cancer and inve…

    Principal investigator: dr hab. Magdalena Stobiecka

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: OPUS 25, Panel: ST4

  3. 203. Biomaterials inducing DNA demethylation as tools for future neuron regeneration therapies

    Principal investigator: dr hab. Katarzyna Nawrotek

    Politechnika Warszawska

    Call: OPUS 25, Panel: ST8

  4. 204. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design…

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  5. 205. Endothelial bioenergetics as a novel target for vascular protection – unveiling the mitochondrial mechanisms of lipid-lo…

    Principal investigator: dr Alicja Małgorzata Braczko

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ5

  6. 206. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 25, Panel: NZ6

  7. 207. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for …

    Principal investigator: dr hab. Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

    Call: OPUS 25, Panel: NZ6

  8. 208. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

    Principal investigator: dr hab. Aleksandra Rutkowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: SONATA 18, Panel: NZ3

  9. 209. Specific immune signatures of T cells as biomarkers of the post-COVID Syndrome and predictors of long-term health dysfun…

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: PRELUDIUM BIS 4, Panel: NZ6

  10. 210. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

    Principal investigator: prof. Rafał Artur Bartoszewski

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 24, Panel: NZ7

  11. 211. Energy storing particles for recharged luminescence bio-tracking and therapy

    Principal investigator: dr hab. Dominika Michalina Wawrzyńczyk

    Politechnika Wrocławska

    Call: OPUS 24, Panel: ST5

  12. 212. Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEb…

    Principal investigator: prof. Zuzanna - Drulis-Kawa

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: JPIAMR ACTION Call 2022, Panel: NZ6

  13. 213. Bisphosphonate complexes based on103Pd/103mRh in vivo generator for Auger electron therapy of bone cancer metastases

    Principal investigator: prof. Aleksander Józef Bilewicz

    Instytut Chemii i Techniki Jądrowej

    Call: OPUS 23, Panel: ST4

  14. 214. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 21, Panel: NZ7

  15. 215. Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies…

    Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 23, Panel: NZ7

  16. 216. Anti-inflammatory effect of senotherapeutic agents on gingival fibroblasts as a potential therapy for periodontitis

    Principal investigator: Alicja Danuta Płonczyńska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 21, Panel: NZ5

  17. 217. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi…

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 23, Panel: NZ7

  18. 218. Photoactivated gold nanoparticles as promising agents for photothermal therapy – in vitro studies in biomimetic membrane…

    Principal investigator: Beata Tim

    Politechnika Poznańska, Wydział Inżynierii Materiałowej i Fizyki Technicznej

    Call: PRELUDIUM 21, Panel: ST5

  19. 219. Interventions against polarisation in society for Trustworthy social media: From diagnosis to therapy

    Principal investigator: dr hab. Katarzyna Budzyńska

    Politechnika Warszawska, Wydział Administracji i Nauk Społecznych

    Call: CHIST-ERA2021, Panel: ST6

  20. 220. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st…

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  21. 221. Treating procrastination - effectiveness and neurobehavioral mechanisms of Cognitive-Behavioral Therapy and Working Time…

    Principal investigator: dr Marek Piotr Wypych

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: OPUS 22, Panel: HS6

  22. 222. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

    Principal investigator: dr Tadeusz Piotr Karcz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  23. 223. Targeting cell surface proteoglycans with high affinity multimeric ligands and their cytotoxic conjugates – towards prec…

    Principal investigator: dr hab. Łukasz Opaliński

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 22, Panel: NZ1

  24. 224. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a…

    Principal investigator: dr hab. Dorota Justyna Łażewska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  25. 225. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  26. 226. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami…

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  27. 227. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

    Principal investigator: dr Anna Piotrowska-Murzyn

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ5

  28. 228. The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy…

    Principal investigator: dr hab. Maciej Stawnisław Sałaga

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM BIS 3, Panel: NZ7

  29. 229. Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC com…

    Principal investigator: dr Anna Agnieszka Marusiak

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA BIS 11, Panel: NZ5

  30. 230. The relationship between hostile attributions and personality disorders symptoms: contextual and cognitive underpinnings…

    Principal investigator: dr hab. Anna Maria Zajenkowska

    Wyższa Szkoła Finansów i Zarządzania w Warszawie

    Call: SONATA BIS 11, Panel: HS6

  31. 231. Phage treatment and wetland technology as intervention strategy to prevent dissemination of antibiotic resistance in sur…

    Principal investigator: dr Małgorzata Dorota Grzesiuk-Bieniek

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

    Call: JPIAMR-ACTION Call 2021, Panel: NZ9

  32. 232. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized…

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ7

  33. 233. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 21, Panel: NZ7

  34. 234. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent…

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 20, Panel: NZ7

  35. 235. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil…

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 20, Panel: NZ7

  36. 236. Breast cancer metastasis-induced endothelial-mesenchymal transition alongside ageing; implications for therapy

    Principal investigator: dr hab. Marta Maria Smęda

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: OPUS 21, Panel: NZ5

  37. 237. Normalization of energy metabolism as a way to develop innovative antithrombotic therapies

    Principal investigator: dr Patrycja Kaczara

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: OPUS 21, Panel: NZ7

  38. 238. Addressing the brain glioma temozolomide therapy limitations

    Principal investigator: dr hab. Joanna Małgorzata Lewandowska-Łańcucka

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 21, Panel: NZ7

  39. 239. Mechanisms involved in heme acquisition - potential targets for therapies directed towards reduction of Porphyromonas gi…

    Principal investigator: dr Michał Sylwester Śmiga

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 21, Panel: NZ6

  40. 240. MLK4 signaling in DNA damage response and cancer therapy

    Principal investigator: Dawid Grzegorz Mehlich

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: PRELUDIUM 20, Panel: NZ3

  41. 241. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  42. 242. Supporting a therapy of non-healing wounds with witch hazel bark

    Principal investigator: Karolina Anna Pawłowska

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 20, Panel: NZ7

  43. 243. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  44. 244. Exploring new roles for ADAR1 in cancer; generation of novel neoantigens, links with p53 and the effects of cancer treat…

    Principal investigator: dr Małgorzata Kurkowiak

    Uniwersytet Gdański, Międzynarodowe Centrum Badań nad Szczepionkami Przeciwnowotworowymi

    Call: WEAVE-UNISONO, Panel: NZ2

  45. 245. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera…

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: WEAVE-UNISONO, Panel: NZ7

  46. 246. Functional framework for viral RNA-dependent RNA polymerase, a major target in COVID19 treatment

    Principal investigator: dr Tomasz Wojciech Turowski

    Instytut Biochemii i Biofizyki PAN

    Call: Polskie Powroty NAWA 2020 COVID-19, Panel: NZ1

  47. 247. MicroRNAome maturation control and its application in selective targeting of cancer stem cells

    Principal investigator: dr Jakub Godlewski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 20, Panel: NZ5

  48. 248. Identification of the interdependence between SWI/SNF-type chromatin remodeling complex, metabolism control and RNA modi…

    Principal investigator: prof. Tomasz Jacek Sarnowski

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 20, Panel: NZ5

  49. 249. Identification of surface proteins as alternate targets for CAR-T therapy against CD19-negative tumors.

    Principal investigator: dr hab. Magdalena Hanna Winiarska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM BIS 2, Panel: NZ6

  50. 250. Targeting deregulated expression of anti-apoptotic proteins belonging to the Bcl-2 family in macrophages as a potential …

    Principal investigator: dr Maja Anna Sochalska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: SONATA 16, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski